Mohammed Al Sharif/LinkedIn
Oct 17, 2026, 02:32
Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
Mohammed Al Sharif, Hematopathologist at King Abdullah bin Abdulaziz University Hospital, shared a post on LinkedIn:
“It was a pleasure to speak at the 10th Hematopathology Overview, organized in collaboration with the Saudi Society of Blood and Marrow Transplantation, where I discussed Factor XIII testing and its clinical significance.
My sincere thanks to the organizing committee for the kind invitation and for putting together such an excellent scientific program.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms
-
Oct 17, 2026, 01:53Kristopher Jonas: Listening to Patients and Recognizing the Donors Who Make Treatment Possible
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism